Oncology

Latest News

Science RF-stock.adobe.com
Verastem Begins Submission for Ovarian Cancer Combination

May 24th 2024

Verastem is studying the combination of avutometinib and defactinib to treat low-grade serous ovarian cancer in patients with KRAS-mutations. The company plans to complete the new drug application in the second half of this year.

appledesign-stock.adobe.com
FDA Approves Bispecific Antibody for Small Cell Lung Cancer

May 17th 2024

FDA Approves Breyanzi for Follicular Lymphoma
FDA Approves Breyanzi for Follicular Lymphoma

May 16th 2024

FDA Accepts BLA for Pancreatic and Lung Cancer Therapy
FDA Accepts BLA for Pancreatic and Lung Cancer Therapy

May 7th 2024

FDA Assigns Action Date for Subcutaneous Opdivo
FDA Assigns Action Date for Subcutaneous Opdivo

May 6th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.